Gene Panel Market by Product & Service, Technique (Amplicon, Hybridization), Design (Predesign, Custom), Application (Cancer, Congenital Disease, Pharmacogenetics) & End User (Hospital, Research Center, Pharmaceutical Companies) - Global Forecasts to 2023
The global gene panel market is expected to reach USD 2.95 Billion by 2023, at a CAGR of 19.2%. The growth of the gene panel market is mainly driven by the increasing prevalence of chronic diseases, growing company initiatives, and rising adoption of gene panel owing to the benefits they offer.
The objectives of this study are as follows:
- To define, describe, and forecast the global gene panel market by product & service, technique, design, application, end user, and region
- To provide detailed information regarding the major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for the key players
- To forecast the size of the market with respect to five regions: North America, Europe, Asia Pacific, and the Rest of the World
- To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze competitive developments in the gene panel market, such as agreements, collaborations, acquisitions, product launches, expansions, and R&D activities
Research Methodology
In the primary research process, various sources from both demand side and supply side were interviewed to obtain qualitative and quantitative information for the report.
For the gene panel market estimation process, both top-down and bottom-up approaches were used to estimate and validate the market size of the gene panel market as well as to estimate the market size of various other dependent submarkets. All possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. This data was consolidated and added to detailed inputs and analysis from MarketsandMarkets and presented in this report. Secondary sources such as National Institute of Health (NIH), American Society of Clinical Oncology, Biotechnology and Biological Sciences Research Council, Department of Biotechnology, European Society of Human Genetics, directories, databases, white papers, annual reports, company house documents, investor presentations, and SEC filings of companies were referred to.
To know about the assumptions considered for the study, download the pdf brochure
The gene panel market is a fragmented market with the presence of several small and big players. Prominent players in this market include Illumina, Inc. (US), BGI (China), Agilent Technologies (US), Eurofins Scientific (US), QIAGEN (Germany), GENEWIZ, Inc. (US), Novogene Corporation (China), Personalis (US), Thermo Fisher Scientific (US), F. Hoffmann-La Roche AG (Switzerland), Integrated DNA Technologies (IDT) (US), GATC Biotech AG (GATC Biotech) (Germany), and ArcherDx (US).
Target Audience for this Report:
- NGS equipment manufacturers, vendors, and distributors
- NGS sequencing services companies
- NGS bioinformatics/data analysis companies
- Research institutes and government organizations
- Venture capitalists and government funding organizations
- Research and consulting firms
- Healthcare institutions
- Pharmaceutical and biotechnology companies
- Contract manufacturing organizations
- Contract research organizations
Gene Panel Market Scope
This report categorizes the gene panel into following segments and subsegments:
By Product & Service
- Test Kits
- Testing Services
By Technique
- Amplicon-based Approach
- Hybridization-based Approach
By Design
- Predesigned Gene Panel
- Customized Gene Panel
By Application
-
Cancer Risk Assessment
- Syndrome-specific
- High-penetrance
- High and Moderate-penetrance
- Comprehensive Cancer Risk
- Diagnosis of Congenital Diseases
- Pharmacogenetics
- Other Applications
By End User
- Research and Academic Institutes
- Hospital and Diagnostic Laboratories
- Pharmaceutical and Biotechnology Companies
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- UK
- France
- RoE
- Asia Pacific
- Rest of the World (RoW)
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company‘s specific needs.
The following customization options are available for this report.
Company Information
Detailed analysis and profiling of additional gene panel market players (up to 5)
This report segments the gene panel market into product & service, technique, design, application, end user, and region. Based on products & services, the market is segmented into test kits and testing services. In 2018, the test kits segment accounted for the largest share of the total market. The growing demand for gene panel in research as well as diagnostics to understand the genetic variability of chronic disorders is propelling the growth of this gene panel market segment.
Based on design, the gene panel market is segmented into predesigned and customized panels. The customized gene panel segment is expected grow at the highest CAGR during the forecast period. This growth is attributed to the evolving needs of the emerging therapeutic and diagnostic application sectors and the increasing number of clinical and preclinical research studies.
Based on applications, the gene panel market is segmented into cancer risk assessment, diagnosis of congenital diseases, pharmacogenetics, and other applications. The cancer risk assessment segment is expected to be the fastest growing during the forecast period due to the increasing incidence of cancer and growing demand for gene panel in research and diagnostics to understand the genetic variability of cancer.
In 2017, North America dominated the gene panel market, followed by Europe. The large share of the North American market can be majorly attributed to the government support for Genomics research. Other growth factors include the presence of leading NGS providers, growing research on cancer and inherited rare diseases, and increasing number of NGS-based & clinical applications in the region.
While the gene panel market presents significant growth opportunities, gene panel market growth may be hindered due to issues related to genetic data security and accuracy & standardization concerns in diagnostic testing.
The gene panel market is fragmented with the presence of several small and big players. Prominent players in this market include Illumina, Inc. (US), Thermo Fisher Scientific (US), Agilent Technologies (US), QIAGEN (Germany), BGI (China), Eurofins Scientific (US), GENEWIZ, Inc. (US), Novogene Corporation (China), Personalis (US), F. Hoffmann-La Roche AG (Switzerland), Integrated DNA Technologies (IDT) (US), GATC Biotech AG (GATC Biotech) (Germany), and ArcherDx (US).
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Table of Contents
1 Introduction (Page No. - 14)
1.1 Objectives of the Study
1.2 Gene Panel Market Definition
1.3 Market Scope
1.3.1 Market Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Gene Panel Market Stakeholders
2 Research Methodology (Page No. - 18)
2.1 Secondary Data
2.2 Primary Data
2.3 Key Industry Insights
2.4 Gene Panel Market Size Estimation
2.5 Market Breakdown and Data Triangulation
2.6 Assumptions for the Study
3 Executive Summary (Page No. - 26)
4 Premium Insights (Page No. - 30)
4.1 Gene Panel Market Overview
4.2 Gene Panel Market, By Type, 2018–2023
4.3 Gene Panel Market, By End User, 2018 vs 2023 (USD Billion)
4.4 Geographic Analysis: Gene Panel Market in Europe, By Application
4.5 Geographical Snapshot of the Gene Panel Market
5 Market Overview (Page No. - 34)
5.1 Introduction
5.2 Gene Panel Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Prevalence of Chronic Diseases
5.2.1.2 Growing Company Initiatives
5.2.1.3 Benefits of Gene Panels
5.2.2 Restraints
5.2.2.1 Issues Related to the Security of Genetic Data
5.2.3 Opportunities
5.2.3.1 Government Initiatives in Population Sequencing
5.2.3.2 Growth Opportunities in Emerging Markets
5.2.4 Challenges
5.2.4.1 Accuracy and Standardization Concerns in Diagnostic Testing
6 Gene Panel Market, By Product & Service (Page No. - 39)
6.1 Introduction
6.2 Test Kits
6.3 Testing Services
7 Gene Panel Market, By Technique (Page No. - 43)
7.1 Introduction
7.2 Amplicon-Based Approach
7.3 Hybridization-Based Approach
8 Gene Panel Market, By Design (Page No. - 47)
8.1 Introduction
8.2 Predesigned Gene Panels
8.3 Customized Gene Panels
9 Gene Panel Market, By Application (Page No. - 51)
9.1 Introduction
9.2 Cancer Risk Assessment
9.2.1 Syndrome-Specific Gene Panels
9.2.2 High-Penetrance Gene Panels
9.2.3 High and Moderate-Penetrance Gene Panels
9.2.4 Comprehensive Cancer Risk Panels
9.3 Pharmacogenetics
9.4 Diagnosis of Congenital Disorders
9.5 Other Applications
10 Gene Panel Market, By End User (Page No. - 59)
10.1 Introduction
10.2 Research & Academic Institutes
10.3 Hospitals & Diagnostic Laboratories
10.4 Pharmaceutical & Biotechnology Companies
11 Gene Panel Market, By Region (Page No. - 64)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 France
11.3.4 Rest of Europe (RoE)
11.4 Asia Pacific
11.5 Rest of the World (RoW)
12 Competitive Landscape (Page No. - 98)
12.1 Overview
12.2 Gene Panel Market Share Analysis
12.3 Competitive Situation and Trends
12.3.1 Agreements, Partnerships, and Collaborations
12.3.2 Product Launches and Upgrades
12.3.3 Acquisitions
12.3.4 Expansions
13 Company Profiles (Page No. - 103)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
13.1 Illumina, Inc.
13.2 Thermo Fisher Scientific Inc.
13.3 Agilent
13.4 Qiagen
13.5 Eurofins Scientific Se
13.6 BGI
13.7 F. Hoffmann-La Roche AG
13.8 Integrated Dna Technologies
13.9 Genewiz, Inc.
13.10 Novogene Corporation
13.11 Personalis, Inc.
13.12 Gatc Biotech AG
13.13 Archerdx
*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.
14 Appendix (Page No. - 132)
14.1 Insights of Industry Experts
14.2 Discussion Guide
14.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
14.4 Introducing RT: Real-Time Market Intelligence
14.5 Available Customizations
14.6 Related Reports
14.7 Author Details
List of Tables (86 Tables)
Table 1 Market, By Product & Service, 2018-2022 (USD Million)
Table 2 Test Kits Market, By Region, 2018-2023 (USD Million)
Table 3 Testing Services Market, By Region, 2018-2023 (USD Million)
Table 4 Market, By Technique, 2016–2023 (USD Million)
Table 5 Market for Amplicon-Based Approach, By Region, 2016–2023 (USD Million)
Table 6 Market for Hybridization-Based Approach, By Region, 2016–2023 (USD Million)
Table 7 Market, By Design, 2018-2022 (USD Million)
Table 8 Predesigned Market, By Region, 2018-2023 (USD Million)
Table 9 Customized Market, By Region, 2018-2023 (USD Million)
Table 10 Market, By Application, 2018-2022 (USD Million)
Table 11 Market for Cancer Risk Assessment, By Region, 2018-2022 (USD Million)
Table 12 Market for Cancer Risk Assessment, By Type, 2018-2022 (USD Million)
Table 13 Syndrome-Specific Market, By Region, 2018-2022 (USD Million)
Table 14 High-Penetrance Market, By Region, 2018-2022 (USD Million)
Table 15 High and Moderate-Penetrance Market, By Region, 2018-2022 (USD Million)
Table 16 Comprehensive Cancer Risk Market, By Region, 2018-2022 (USD Million)
Table 17 Market for Pharmacogenetics, By Region, 2018-2022 (USD Million)
Table 18 Market for the Diagnosis of Congenital Disorders, By Region, 2018-2022 (USD Million)
Table 19 Market for Other Applications, By Region, 2018-2022 (USD Million)
Table 20 Market, By End User, 2016–2023 (USD Million)
Table 21 Market for Research & Academic Institutes, By Region, 2016–2023 (USD Million)
Table 22 Market for Hospitals & Diagnostic Laboratories, By Region, 2016–2023 (USD Million)
Table 23 Market for Pharmaceutical & Biotechnology Companies, By Region, 2016–2023 (USD Million)
Table 24 Market, By Region, 2016–2023 (USD Million)
Table 25 North America: Market, By Country, 2016–2023 (USD Million)
Table 26 North America: Market, By Product & Service, 2016–2023 (USD Million)
Table 27 North America: Market, By Technique, 2016–2023 (USD Million)
Table 28 North America: Market, By Design, 2016–2023 (USD Million)
Table 29 North America: Market, By Application, 2016–2023 (USD Million)
Table 30 North America: Market for Cancer Risk Assessment, By Type, 2016–2023 (USD Million)
Table 31 North America: Market, By End User, 2016–2023 (USD Million)
Table 32 US: Market, By Product & Service, 2016–2023 (USD Million)
Table 33 US: Market, By Technique, 2016–2023 (USD Million)
Table 34 US: Market, By Design, 2016–2023 (USD Million)
Table 35 US: Market, By Application, 2016–2023 (USD Million)
Table 36 US: Market for Cancer Risk Assessment, By Type, 2016–2023 (USD Million)
Table 37 US: Market, By End User, 2016–2023 (USD Million)
Table 38 Canada: Market, By Product & Service, 2016–2023 (USD Million)
Table 39 Canada: Market, By Technique, 2016–2023 (USD Million)
Table 40 Canada: Market, By Design, 2016–2023 (USD Million)
Table 41 Canada: Market, By Application, 2016–2023 (USD Million)
Table 42 Canada: Market for Cancer Risk Assessment, By Type, 2016–2023 (USD Million)
Table 43 Canada: Market, By End User, 2016–2023 (USD Million)
Table 44 Europe: Gene Panel Market, By Country, 2016–2023 (USD Million)
Table 45 Europe: Market, By Product & Service, 2016–2023 (USD Million)
Table 46 Europe: Market, By Technique, 2016–2023 (USD Million)
Table 47 Europe: Market, By Design, 2016–2023 (USD Million)
Table 48 Europe: Market, By Application, 2016–2023 (USD Million)
Table 49 Europe: Market for Cancer Risk Assessment, By Type, 2016–2023 (USD Million)
Table 50 Europe: Market, By End User, 2016–2023 (USD Million)
Table 51 Germany: Market, By Product & Service, 2016–2023 (USD Million)
Table 52 Germany: Gene Panel Market, By Technique, 2016–2023 (USD Million)
Table 53 Germany: Market, By Design, 2016–2023 (USD Million)
Table 54 Germany: Market, By Application, 2016–2023 (USD Million)
Table 55 Germany: Market for Cancer Risk Assessment, By Type, 2016–2023 (USD Million)
Table 56 Germany: Market, By End User, 2016–2023 (USD Million)
Table 57 UK: Market, By Product & Service, 2016–2023 (USD Million)
Table 58 UK: Market, By Technique, 2016–2023 (USD Million)
Table 59 UK: Market, By Design, 2016–2023 (USD Million)
Table 60 UK: Market, By Application, 2016–2023 (USD Million)
Table 61 UK: Market for Cancer Risk Assessment, By Type, 2016–2023 (USD Million)
Table 62 UK: Market, By End User, 2016–2023 (USD Million)
Table 63 France: Market, By Product & Service, 2016–2023 (USD Million)
Table 64 France: Market, By Technique, 2016–2023 (USD Million)
Table 65 France: Market, By Design, 2016–2023 (USD Million)
Table 66 France: Market, By Application, 2016–2023 (USD Million)
Table 67 France: Market for Cancer Risk Assessment, By Type, 2016–2023 (USD Million)
Table 68 France: Market, By End User, 2016–2023 (USD Million)
Table 69 RoE: Market, By Product & Service, 2016–2023 (USD Million)
Table 70 RoE: Market, By Technique, 2016–2023 (USD Million)
Table 71 RoE: Market, By Design, 2016–2023 (USD Million)
Table 72 RoE: Market, By Application, 2016–2023 (USD Million)
Table 73 RoE: Market for Cancer Risk Assessment, By Type, 2016–2023 (USD Million)
Table 74 RoE: Market, By End User, 2016–2023 (USD Million)
Table 75 APAC: Market, By Product & Service, 2016–2023 (USD Million)
Table 76 APAC: Market, By Technique, 2016–2023 (USD Million)
Table 77 APAC: Market, By Design, 2016–2023 (USD Million)
Table 78 APAC: Market, By Application, 2016–2023 (USD Million)
Table 79 APAC: Market for Cancer Risk Assessment, By Type, 2016–2023 (USD Million)
Table 80 APAC: Gene Panel Market, By End User, 2016–2023 (USD Million)
Table 81 RoW: Market, By Product & Service, 2016–2023 (USD Million)
Table 82 RoW: Market, By Technique, 2016–2023 (USD Million)
Table 83 RoW: Market, By Design, 2016–2023 (USD Million)
Table 84 RoW: Market, By Application, 2016–2023 (USD Million)
Table 85 RoW: Market for Cancer Risk Assessment, By Type, 2016–2023 (USD Million)
Table 86 RoW: Market, By End User, 2016–2023 (USD Million)
List of Figures (38 Figures)
Figure 1 Market Segmentation
Figure 2 Research Design
Figure 3 Key Data From Secondary Sources
Figure 4 Key Data From Primary Sources
Figure 5 Market Size Estimation: Bottom-Up Approach
Figure 6 Market Size Estimation: Top-Down Approach
Figure 7 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 8 Data Triangulation Methodology
Figure 9 Market, By Type, 2018 vs 2023 (USD Billion)
Figure 10 Market, By Technique, 2018 vs 2023 (USD Billion)
Figure 11 Market, By Design, 2018 vs 2023 (USD Billion)
Figure 12 Market, By Application, 2018 vs 2023 (USD Billion)
Figure 13 Market, By End User, 2018 vs 2023 (USD Billion)
Figure 14 Global Market, By Region, 2018–2023
Figure 15 Increasing Prevalence of Chronic Diseases One of the Major Factors Driving the Growth of the Global Market
Figure 16 Testing Services Segment to Register the Highest Growth During the Forecast Period
Figure 17 Research and Academic Institutes to Continue to Dominate the Market in 2023
Figure 18 Cancer Risk Assessment to Account for the Largest Share of the Gene Panel Market in Europe in 2018
Figure 19 US to Dominate the Market in 2018
Figure 20 Market: Drivers, Restraints, Opportunities, and Challenges
Figure 21 Test Kits Accounted for Largest Share of the Market in 2018
Figure 22 Amplicon-Based Approach to Resister the Highest Growth Rate During the Forecast Period
Figure 23 Predesigned Gene Panels to Account for the Largest Share of the Market in 2018
Figure 24 Cancer Risk Assessment Accounted for Largest Share of the Market in 2018
Figure 25 Research & Academic Institutes to Account for Largest Share of the Market in 2018
Figure 26 North America: Market Snapshot, 2018
Figure 27 Europe: Market Snapshot, 2018
Figure 28 Asia Pacific: Market Snapshot, 2018
Figure 29 Rest of the World: Market Snapshot, 2018
Figure 30 Key Developments in the Market From 2015 to 2018
Figure 31 Market Evolution Framework
Figure 32 Gene Panel Test Kits Market Share Analysis, By Key Player (2017)
Figure 33 Illumina, Inc.: Company Snapshot (2017)
Figure 34 Thermo Fisher Scientific: Company Snapshot (2017)
Figure 35 Agilent: Company Snapshot (2017)
Figure 36 Qiagen: Company Snapshot (2017)
Figure 37 Eurofins Scientific Se: Company Snapshot (2017)
Figure 38 F. Hoffmann-La Roche AG: Company Snapshot (2017)
Generating Response ...
Growth opportunities and latent adjacency in Gene Panel Market